Replies to post #4 on Medexus Pharmaceuticals Inc (MEDXF)

[ronpopeil]

I like this one a lot. Strong revenues. Possible FDA approval for treosulfan (sp?) in august which could add another $150+ million in revenues plus nasdaq uplisting. Very undervalued